NRG Therapeutics selects Domainex for project aimed at finding candidate for neurogenerative disorders
A neuroscience company targeting mitochondrial dysfunction has teamed up with an organization developing small molecule…
30/06/2022 - 3 minutes
A neuroscience company targeting mitochondrial dysfunction has teamed up with an organization developing small molecule…
4BIO Capital, an international venture capital firm focusing on the advanced therapies sector, has co-led…